The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFIRINOX: The best adjuvant treatment for ampullary adenocarcinoma?
 
Ali? Kalem
No Relationships to Disclose
 
Tulay Kus
No Relationships to Disclose
 
Taha Koray Sahin
No Relationships to Disclose
 
Omer Dizdar
No Relationships to Disclose
 
Safa Can Efil
No Relationships to Disclose
 
Talat Aykut
No Relationships to Disclose
 
Hatice Bolek
No Relationships to Disclose
 
Nadiye Sever
No Relationships to Disclose
 
Eyyüp Çavdar
No Relationships to Disclose
 
muhammed Fatih Sagiroglu
No Relationships to Disclose
 
Tugce Kubra Gunes
No Relationships to Disclose
 
Berkan Karabuga
No Relationships to Disclose
 
Savas Gokcek
No Relationships to Disclose
 
Seray Saray
No Relationships to Disclose
 
Ferit Aslan
No Relationships to Disclose
 
Omer Acar
No Relationships to Disclose
 
Mustafa Seyyar
No Relationships to Disclose
 
Gokmen Aktas
No Relationships to Disclose
 
Suayib Yalcin
Stock and Other Ownership Interests - Humana; Pfizer
Honoraria - Gen
Consulting or Advisory Role - Amgen; Bayer; bms; Gen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - Bayer; Bayer; gen ilaç; Merck Serono; Novartis; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Gen; Roche